|
Video: What is a Stock Split?
|
|
Clearside Biomedical is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space, or SCS. Co.'s SCS injection platform, utilizing its proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Co.'s SCS injection platform can be used in conjunction with existing drugs designed for delivery to the SCS, therapies and future therapeutic inventions. According to our CLSD split history records, Clearside Biomedical has had 0 splits. | |
|
Clearside Biomedical (CLSD) has 0 splits in our CLSD split history database.
Looking at the CLSD split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Clearside Biomedical shares, starting with a $10,000 purchase of CLSD, presented on a split-history-adjusted basis factoring in the complete CLSD split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/03/2016 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$7.06 |
|
End price/share: |
$1.67 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-76.35% |
|
Average Annual Total Return: |
-16.84% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,364.81 |
|
Years: |
7.82 |
|
|
|
|
|